Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in mice

延长SARS-CoV-2 RBD加强免疫接种可诱导小鼠产生体液和细胞免疫耐受。

阅读:4
作者:Feng-Xia Gao ,Rui-Xin Wu ,Mei-Ying Shen ,Jing-Jing Huang ,Ting-Ting Li ,Chao Hu ,Fei-Yang Luo ,Shu-Yi Song ,Song Mu ,Ya-Nan Hao ,Xiao-Jian Han ,Ying-Ming Wang ,Luo Li ,Sheng-Long Li ,Qian Chen ,Wang Wang ,Ai-Shun Jin

Abstract

The repetitive applications of vaccine boosters have been brought up in face of continuous emergence of SARS-CoV-2 variants with neutralization escape mutations, but their protective efficacy and potential adverse effects remain largely unknown. Here, we compared the humoral and cellular immune responses of an extended course of recombinant receptor binding domain (RBD) vaccine boosters with those from conventional immunization strategy in a Balb/c mice model. Multiple vaccine boosters after the conventional vaccination course significantly decreased RBD-specific antibody titers and serum neutralizing efficacy against the Delta and Omicron variants, and profoundly impaired CD4+ and CD8+T cell activation and increased PD-1 and LAG-3 expressions in these T cells. Mechanistically, we confirmed that extended vaccination with RBD boosters overturned the protective immune memories by promoting adaptive immune tolerance. Our findings demonstrate potential risks with the continuous use of SARS-CoV-2 vaccine boosters, providing immediate implications for the global COVID-19 vaccination enhancement strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。